Self-Assessment: Clinical Approach to MG and Autoantibodies and the Evolving MG Landscape

From 2022 Annual Meeting Session Content

Course Description

Learn about diagnosis and therapies to manage myasthenia gravis through this self-assessment course created from two complimentary courses from the 2022 Annual Meeting.

Clinical Approach to MG Therapies
Review the role of various therapies and challenges faced by clinicians in the management of MG. This session will be a case-based clinician's approach to traditional and novel therapies in the management of MG.

Autoantibodies and the Evolving MG Landscape
Identify antibodies supportive of the diagnosis of autoimmune MG; describe the clinical presentation of MG based on Ab status; discuss the utility of other confirmatory tests for MG; discuss established therapies for MG; review the definition of refractory MG; describe promising therapies for autoimmune MG; review cautionary drugs in MG; discuss the effectiveness of thymectomy, rituximab and methotrexate; and describe the impact of immune checkpoints inhibitors on MG.

To claim self-assessment (SA) credit, you must watch the session recordings and answer a post-test. You must get above a 70% on the post-test survey to claim credit.

The American Board of Psychiatry and Neurology (ABPN) and the American Board of Physical Medicine and Rehabilitation (ABPMR) have reviewed and approved this product as part of a comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of maintenance of certification (MOC).

ACCREDITATION STATEMENT : The AANEM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Summary


Availability:	On-Demand
	Expires on 10/15/2025


Cost:	$50.00


Credit Offered:	3 SA CME Credits 3 CEU Credits